ReviewInternational journal of nanomedicine2026
Innovative Applications of Nanomaterials in the Diagnosis and Treatment of Ocular Diseases: Targeted Delivery, Intelligent Therapy, Diagnostic Breakthroughs, and Synergistic Strategies with Stem Cells and Biomaterials.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The complex physiological structures and multiple biological barriers of the eye pose significant challenges to drug delivery, resulting in poor absorption and limited therapeutic efficacy of conventional treatments. In this review, nanomaterials with their distinctive physicochemical properties and biocompatibility have emerged as essential tools in the diagnosis and treatment of ocular diseases. We summarized the latest advancements in the application of nanomaterials for targeted drug delivery, smart therapeutic strategies, and early diagnostic technologies specific to ocular diseases. This work provides a comprehensive analysis of the design concepts, biocompatibility, and controlled release mechanisms of various nanocarriers. It also examines their therapeutic potential in inflammatory eye diseases and retinal degenerative conditions. Additionally, the advantages of naturally derived nanomaterials and their potential applications in ocular drug delivery systems are explored. Furthermore, the role of stem cell therapies in enhancing tissue regeneration and supporting treatment efficacy is discussed. In the future, this review discusses the integration of nanotechnology with artificial intelligence to advance the development of precision medicine in ophthalmology by elucidating their synergistic roles. The aim of this article is to provide researchers and clinicians with a systematic theoretical foundation and practical guidelines to promote the clinical translation and application of nanomaterials in the field of ophthalmology. Distinct from existing reviews, this work integrates nanomaterial design advances with stem cell therapy, artificial intelligence and smart responsive systems, comprehensively addresses clinical translation challenges, and provides a forward-looking perspective on personalized ophthalmic medicine, filling the gap of lacking a holistic cross-disciplinary summary in current literature.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.